ArticleFrontiers in oncology2022

Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma.

Zheng Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.